Cargando…
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer
[Image: see text] Aldehyde dehydrogenases (ALDHs) are overexpressed in various tumor types including prostate cancer and considered a potential target for therapeutic intervention. 4-(Diethylamino)benzaldehyde (DEAB) has been extensively reported as a pan-inhibitor of ALDH isoforms, and here, we rep...
Autores principales: | Ibrahim, Ali I. M., Batlle, Elisabet, Sneha, Smarakan, Jiménez, Rafael, Pequerul, Raquel, Parés, Xavier, Rüngeler, Till, Jha, Vibhu, Tuccinardi, Tiziano, Sadiq, Maria, Frame, Fiona, Maitland, Norman J., Farrés, Jaume, Pors, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007462/ https://www.ncbi.nlm.nih.gov/pubmed/35212533 http://dx.doi.org/10.1021/acs.jmedchem.1c01367 |
Ejemplares similares
-
Design, Synthesis, Biological Evaluation and In Silico Study of Benzyloxybenzaldehyde Derivatives as Selective ALDH1A3 Inhibitors
por: Ibrahim, Ali I. M., et al.
Publicado: (2021) -
Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3
por: Castellví, Albert, et al.
Publicado: (2022) -
4-(Diethylamino)salicylaldehyde azine
por: Qiu, Jing-Bo, et al.
Publicado: (2011) -
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target
por: Quattrini, Luca, et al.
Publicado: (2020) -
Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies
por: Sneha, Smarakan, et al.
Publicado: (2021)